Atorvastatin exerts dual effects of lesion regression and ovarian protection in the prevention and treatment of endometriosis
European Journal of Pharmacology · 2024
DOI: 10.1016/j.ejphar.2023.176261 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2024. Verfasst von Xian Qin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Women and Children's Hospital of Chongqing Medical University, Chongqing 401147, China; Department of Obstet…. Hauptthemen laut MEDLINE: Endometriosis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Endometriosis is a frequent, chronic, estrogen-dependent and inflammatory gynecological disease leading to pain and infertility. Clinical and metabolic studies reveal that patients with endometriosis are susceptible to hyperlipemia and lipid dysfunction, putting them at ascending risk of cardiovascular diseases. Statins constitute a group of cholesterol-lowering drugs with pleiotropic effects. A plethora of researches have proved their ability to inhibit the growth of ectopic lesions in endometriosis. However, concerns exist about their possible adverse effects on ovarian function. This study aimed to investigate the possible effect of atorvastatin on the ovarian endocrine function and fertility capacity in the prevention and treatment of endometriosis. Here, 5 mg/kg atorvastatin was intraperitoneally injected to the endometriosis mice once a day for consecutive fourteen days during and after the development of endometriotic implants. The results indicated that atorvastatin not only led to regression of the ectopic lesions, but also caused no discernible harm to the ovary for both the preventive and the therapeutic models. In addition, it elicited a protective effect on the ovarian reserve and fertility possibly by reducing inflammation in the ovary. Hence, atorvastatin could be a promising drug for endometriosis prevention and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Women and Children's Hospital of Chongqing Medical University, Chongqing 401147, China; Department of Obstetrics and Gynecology, Chongqing Health Center for Women and Children, C…
- Department of Obstetrics and Gynecology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
Zitieren
APA
Qin, X., Wang, Q., Xu, D., Sun, Y., Xu, W., Wang, B., Yang, Z., & Hao, L. (2024). Atorvastatin exerts dual effects of lesion regression and ovarian protection in the prevention and treatment of endometriosis. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2023.176261
Vancouver
Qin X, Wang Q, Xu D, Sun Y, Xu W, Wang B, et al. Atorvastatin exerts dual effects of lesion regression and ovarian protection in the prevention and treatment of endometriosis. European Journal of Pharmacology. 2024. doi:10.1016/j.ejphar.2023.176261
BibTeX
@article{Qin2024,
author = {Qin, Xian and Wang, Qian and Xu, Dongmei and Sun, Yixuan and Xu, Wandong and Wang, Bo and Yang, Zhu and Hao, Lijuan},
title = {Atorvastatin exerts dual effects of lesion regression and ovarian protection in the prevention and treatment of endometriosis},
journal = {European Journal of Pharmacology},
year = {2024},
doi = {10.1016/j.ejphar.2023.176261}
}
EUVIMED